SCOPUS 정보 검색 플랫폼

British Journal of Clinical Pharmacology

Volumn 75, Issue 1, 2013, Pages 254-259

Pioglitazone and bladder cancer: A propensity score matched cohort study

(3) Wei, Li a Macdonald, Thomas M a Mackenzie, Isla S a

a UNIVERSITY OF DUNDEE (United Kingdom)

Author keywords

Bladder cancer; Cohort study; Pioglitazone

Indexed keywords

PIOGLITAZONE;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INDUCED CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROPENSITY SCORE;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; THIAZOLIDINEDIONES; URINARY BLADDER NEOPLASMS;

EID: 84871113059 PISSN: 03065251 EISSN: 13652125 Source Type: Journal
DOI: 10.1111/j.1365-2125.2012.04325.x Document Type: Article

Times cited : (89)

References (9)

1
- 79956217900
- Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study
- Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, Quesenberry CP Jr, Vaughn DJ, Nessel L, Selby J, Strom BL. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 2011; 34: 916-22.
- (2011) Diabetes Care , vol.34 , pp. 916-922
- Lewis, J.D.¹ Ferrara, A.² Peng, T.³ Hedderson, M.⁴ Bilker, W.B.⁵ Quesenberry Jr, C.P.⁶ Vaughn, D.J.⁷ Nessel, L.⁸ Selby, J.⁹ Strom, B.L.¹⁰

2
- 84871131283
- European Medicines Agency. Recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer. Available at (last accessed 8 June 2012).
- European Medicines Agency. Recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer. 2011. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail001311.jsp&mid=WC0b01ac058004d5c1 (last accessed 8 June 2012).
- (2011)

3
- 61349191610
- A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure
- Mujib M, Aban I, White M, Aronow WS, Ahmed A. A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure. Am J Cardiol 2009; 103: 839-44.
- (2009) Am J Cardiol , vol.103 , pp. 839-844
- Mujib, M.¹ Aban, I.² White, M.³ Aronow, W.S.⁴ Ahmed, A.⁵

4
- 84871139417
- The General Practice Research Database: observational data. Available at (last accessed 8 June 2012).
- The General Practice Research Database: observational data. 2012. Available at http://www.cprd.com/intro.asp (last accessed 8 June 2012).
- (2012)

5
- 0031639661
- Use and misuse of population attributable fractions
- Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-9.
- (1998) Am J Public Health , vol.88 , pp. 15-19
- Rockhill, B.¹ Newman, B.² Weinberg, C.³

6
- 77649144555
- Pioglitazone: side effect and safety profile
- Shah P, Mudaliar S. Pioglitazone: side effect and safety profile. Expert Opin Drug Saf 2010; 9: 347-54.
- (2010) Expert Opin Drug Saf , vol.9 , pp. 347-354
- Shah, P.¹ Mudaliar, S.²

7
- 84871118965
- Pioglitazone: risk of bladder cancer. Available at (last accessed 6 June 2012).
- Pioglitazone: risk of bladder cancer. 2012. Available at http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON125962 (last accessed 6 June 2012).
- (2012)

8
- 79960164790
- Diabetes drug may be associated with increase in risk of bladder cancer
- Stephenson J. Diabetes drug may be associated with increase in risk of bladder cancer. JAMA 2011; 306: 143.
- (2011) JAMA , vol.306 , pp. 143
- Stephenson, J.¹

9
- 0032494717
- Confidence intervals for the number needed to treat
- Altman DG. Confidence intervals for the number needed to treat. BMJ 1998; 317: 1309-12.
- (1998) BMJ , vol.317 , pp. 1309-1312
- Altman, D.G.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.